Neudle.com: senile dementia

Differential
(Click to cross reference)

abiotrophy

abstract reasoning

acalculia

acetylcholine

acetylcholine in CNS

acetylcholine receptor

acetylcholinesterase

acetyl-L-carnitine

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome, older adults

activities of daily living

activities of daily living scale

aducanumab

advance directives

advances in neurology

adverse drug reaction

age associated memory impairment

alcohol, neurologic complications with

Alzheimer's disease associated protein

Alzheimer's disease, age of onset

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, conjugal

Alzheimer's disease, diagnosis of

Alzheimer's disease, driving with

Alzheimer's disease, early onset

Alzheimer's disease, early symptoms

Alzheimer's disease, familial

Alzheimer's disease, familial, late onset

Alzheimer's disease, heterogeneity of

Alzheimer's disease, incidence

Alzheimer's disease, misdiagnosis

Alzheimer's disease, noncognitive symptoms

Alzheimer's disease, pathogenesis

Alzheimer's disease, patient awareness of

Alzheimer's disease, preclinical

Alzheimer's disease, prognosis of

Alzheimer's disease, rapidly progressive

Alzheimer's disease, rate of clinical decline

Alzheimer's disease, risk factors in

Alzheimer's disease, staging

Alzheimer's disease, telling patient diagnosis of

Alzheimer's disease, treating associated medical problems in

Alzheimer's disease, treatment of

Alzheimer's disease, vaccine

Alzheimer's disease, visual variant

amnesia

amygdala

amyloid

amyloid angiopathy, cerebral

amyloid beta protein

amyloid beta protein antibodies

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

anatomy of

aneuploidy

aneurysm, intracranial, familial

angiotensin II receptor blocker

anticholinergic drugs

anticholinesterase

anticoagulant, treatment

aphasia, logopenic, progressive

aphasia, progressive

aphasia, progressive, primary

aphasia, transcortical

aphasia, transcortical-sensory

apnea

apolipoprotein E

apolipoprotein E, false positive

apoliprotein E, plasma level

apraxia, constructional

autonomic dysfunction

Balint's syndrome

basilar artery migraine

behavior

behavior modification

behavior, combative

behavioral disorder

benign essential tremor

benign senescent forgetfulness

benzodiazepine

beta adrenergic blocker

bovine spongiform encephalopathy

brain biopsy, complications of

brain biopsy, false negative

brain biopsy, indication

brain transplantation

burst suppression pattern, electroencephalogram

cardiac arrest and resuscitation

caregiver

carotid artery stenosis

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, indications for

CAT scan, normal ventricular size with aging

cell fusion test

central nervous system, infection of

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar plaques, amyloid

cerebral blood flow

cerebral cortical atrophy

cerebral death

cerebral dominance

cerebral edema

cerebral edema, vasogenic

cerebral glucose metabolism

cerebral hemisphere left-right asymmetry

cerebral infarction

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, enzymes in

cerebrospinal fluid, hydroxyindoleacetic acid, 5(5-HIAA)

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, serotonin

cerebrovascular accident

cerebrovascular accident, multiple

cerebrovascular accident, recurrent

cerebrovascular accident, silent

cerebrovascular disease

Charles Bonnet's syndrome

chelation therapy

choline acetyltransferase

chromosomal abnormality

cingulate island sign

cinnarizine

cisternogram, radionuclide

citalopram

claustrophobia

clindamycin

Clinical Pathologic Conference(C.P.C.)

color vision, impaired

color vision, impaired, cerebral

comorbidities

competency

complications

comprehension, impaired

conflict of interest

confusion

congenital malformation

congenital malformation, non CNS

constipation

contraindications

controversies in neurology

corpus callosum

corpus callosum, atrophy of

corpus callosum, neoplasm of

cortical-basal ganglionic degeneration

corticotropin-releasing factor

degenerative diseases of CNS

dementia, age at onset

dementia, cerebrovascular disease causing

dementia, clinical diagnosis

dementia, diagnostic classification

dementia, diagnostic evaluation of

dementia, differential diagnosis of

dementia, driving with

dementia, early detection

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, incidence

dementia, mixed

dementia, posttraumatic

dementia, preexisting in stroke patient

dementia, presenile

dementia, prevalence of

dementia, prevention of

dementia, rapidly progressive

dementia, reversible

dementia, screening for

dementia, transmissible

dementia, treatment of

dementia, unknown etiology

denial of illness

deprenyl

depression

depth perception, impaired

differential diagnosis

dihydroepiandosterone

dimebon

disability rating scale, neurological

disability, neurological

disease modifying agents

dopamine beta hydroxylase

drug induced neurologic disorders

dysexecutive syndrome

dyskinesia, buccal lingual facial

dystonia, drug induced

dystonia, focal

dystonia, post traumatic

dystonia, treatment of

dystonic reaction, acute

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, focal delta activity

electroencephalogram, periodic complexes

electroencephalogram, spike activity

electromagnetic fields

electromyogram

electron microscopy

electronic monitoring

employment

encephalitis, viral

encephalopathy, anoxic

endocarditis, native-valve

enkephalins

enzyme inhibition

enzyme, defect

epidemiology of neurology

ethics in neurology

evidence-based research

evoked potentials

excitotoxin

executive dysfunction

exercise

expert witness, medical

fatal familial insomnia

fever

fibrinolytic agents, utilization

finger nose finger test

football neurologic injuries

fracture, long bone

Friedreich's ataxia

frontal lobe, anatomy and physiology

frontal lobe, atrophy

frontal lobe, behavior with disease of

frontal lobe, lesion of

frontal lobe, pathologic signs of

gastrostomy, percutaneous endoscopic

gaze palsy

gaze palsy, horizontal

genetic neurologic disorders

genetic screening

genetic testing

Gerstmann syndrome

Gerstmann-Straussler-Scheinker disease

Gilles de la Tourette syndrome

glioblastoma multiforme(astrocytoma Gr.III)

glioma

glutamic acid

GPS tracking

granulovacuolar degeneration

grasping

gray matter

hallucination

hallucination, auditory

hallucination, visual

hallucination, visual, benign

haloperidol

handedness

head injury

head injury, hydrocephalus following

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hemorrhagic diathesis

hemosiderosis of CNS, superficial

hemosiderosis, subarachnoid

hepatitis

heralding manifestation

herbs

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

histamine-2 receptor blockers

histochemistry

HMGcoA reductase inhibitors

hydrocephalus, normal pressure

hyperpyrexia, CNS disorder causing

hyperreflexia

hypertension

hypertension, cerebrovascular disease with

hypertropia

hyposmia

hypotension, systemic

hypoxia

hypoxic encephalopathy

iatrogenic neurologic disorders

imbalance, postural

immunization, neurologic complications with

immunoperoxidase staining

inappropriate behavior

inattention

inclusion bodies

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intracytopasmic

inclusion bodies, location of

intellectual deterioration

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, small

intranasal medication

Jakob-Creutzfeldt disease

Jakob-Creutzfeldt disease, variant

Jakob-Creutzfeldt disease, young adult

judgement, impaired

Kluver-Bucy syndrome

kuru

laboratory values, normal

L-dopa, drug interactions with and side effects of

lecanemab

lecithin

left-right orientation

leukoencephalitis, acute necrotizing hemorrhagic

Lewy body

Lewy body disease, diffuse

life expectancy

life support, withdrawal of

lifestyle

limbic system

limbic-predominant age-related TDP-43 encephalopathy

line bisection task

lipid lowering agent

lipid storage disorder of CNS

lipoma of CNS

liver disease

liver function enzymes

lobar atrophy

locus ceruleus, lesion of

logopenia

lymphoma involving CNS

machine learning

managed care

manganese intoxication

manic-depressive

marital status

medical-legal aspects of neurology

medication withdrawal

Memory Impairment Screen

memory, defect of recent

memory, disorder, treatment of

memory, evaluation of

memory, impairment of

memory, impairment of, isolated

memory, impairment of, subjective

memory, recent

meningoencephalitis

menopause

mental status, evaluation of

metrifonate

microhemorrhage, intracerebral

microtubule

migraine

mild cognitive impairment

mild cognitive impairment converting to Alzheimer's disease

mimics

Mini Mental Status Examination

misdiagnosis

misdirection

misidentification

mitochondrial disease

molecular genetics

mongolism

monoamine oxidase inhibitors

monoclonal antibodies

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, false negative

MRI, field strength, high

MRI, susceptibility weighted

MRI, volumetry

MRI, voxel-based morphometry

MRS

multiple sclerosis

multiple sclerosis, diagnosis of

multiple system atrophy

murder

muscarinic agonist

muscular dystrophy

muscular dystrophy, Duchenne

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve conduction studies

nerve growth factor

neurofibrillary degeneration

neurofibromatosis 1

neurofibromatosis 2

neuroleptic

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination

neurologic history

neurologic signs

neurologic symptoms

neuronal degeneration

neuronal loss

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, amyloid

neuroprotective agents

non-dominant hemisphere

nonsteroidal anti-inflammatory drug

nucleus basalis of Meynert

nursing home

nylidrin

obsessive-compulsive disorder

occupational neurologic disorders

olanzapine

old age, driving and

old age, neurology of

olfactory bulb

optic nerve, lesion of

optic neuropathy

orthostatic hypotension

parietal lobe, atrophy

parietal lobe, lesion of

parietal lobe, syndromes of

Parkinson disease

Parkinson disease, arteriosclerotic

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, presymptomatic detection

Parkinson disease, prognosis of

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

PAS positive material in the brain

pathologic reflex

pathology

patient information and support

peduncular hallucinosis

peptides, brain

perihippocampal fissure

perimetry

perimetry, computerized

persistent vegetative state

persistent vegetative state, children

persistent vegetative state, etiology of

Pittsburgh Compound B

placebo

pleocytosis of cerebrospinal fluid

pneumoencephalogram(PEG)

pneumonia

polyneuropathy

posterior cerebral artery occlusion

posterior cortical atrophy

posterior leukoencephalopathy syndrome

postoperative neurologic complications

prevention of neurologic disorders

prion disease

progesterone

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive supranuclear palsy

protein 14-3-3, cerebrospinal fluid

pseudobulbar palsy

pseudodementia

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

psychosis

psychotic behavior

pupil

pupil, abnormality in neurologic disorders

pure autonomic failure

pursuit eye movements, abnormal

pyramidal tract dysfunction

rapidly progressing neurologic illness

reading

reading disorder, acquired

reading problem, causes of

recombinant DNA

recurrent

reduplicative paramnesia

reflex sympathetic dystrophy

release phenomena

REM sleep

REM sleep behavior disorder

repetitive questioning

research

retinal degeneration

retrocollis

reversible cerebral vasoconstrictive syndromes

rheumatoid arthritis, neurologic complications of

rhinorrhea, CSF

rigidity

risk factors

risk factors, modification

risk-benefit assessment

saccadic eye movements, abnormal

safety

salivation, excessive

seizure, diagnosis of

seizure, psychomotor-temporal lobe

seizure, risk factors for

seizure, surgical treatment of

selective serotonin reuptake inhibitors

serum alanine aminotransferase

sexual behavior, disorder of

shadowing

shared decision making

sildenafil

simultanagnosia

simvastatin

single photon emission computed tomography

single photon emission computed tomography, false negative

skin, biopsy

skin, lesions in neurologic disorders

sleep

sleep apnea

sleep pathology and physiology

smell

Smell Identification Test

snoring

snout reflex

sodium-glucoe cotransporter-2 inhibitors

speech disorder

speech, loss of

spinal cord, injury of

spinal muscular atrophy

spinocerebellar ataxia

spinocerebellar ataxia type 1

spongy degeneration of brain

staining reactions in neuropathology

startle myoclonus

statin therapy

stem cell transplantation

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

stooped posture

stress, emotional

stridor

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

temporal lobe, atrophy

temporal lobe, lesion

temporal lobe, lesion, bilateral

tetrahydroaminoacridine

tissue plasminogen activator, intravenous

tonic foot response

torticollis

torticollis, post traumatic

TRAILBLAZER-ALZ trial

trauma

trazodone

treatment of neurologic disorder

treatment, non-pharmacologic

TREM2 variants

tremor

tremor, post traumatic

tremor, resting

trifluoperazine

trinucleotide repeats

vaccination, neurologic complications with

vasodilating agents in treatment of cerebrovascular disease

velnacrine

ventricular enlargement

visual acuity, decreased

visual evoked response

visual field defect

visual field testing

visual fields

visual fields, constricted

visuospatial disturbance

vitamin E

vitamin supplementation

vitamin therapy

walking, difficulty with

white matter disease, periventricular

whites

word-finding difficulty

workup

WORLD spelling test

writing

Showing articles 150 to 200 of 2347 << Previous Next >>

Mild Cognitive Impariment is Early-Stage Alzheimer Disease
Arch Neurol 63:15-16, Morris,J.C., 2006

A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Arch Neurol 63:49-54, Reisberg,B.,et al, 2006

Coxibs and Alzheimers Disease: Should They Stay or Should They Go?
Ann Neurol 59:219-228, Firuzi,O. &Pratico,D., 2006

The Parkinsons Complex: Parkinsonism Is Just the Tip of the Iceberg
Ann Neurol 59:591-596, Langston,J.W., 2006

Effect of Enhanced Psychosocial Care on Antipsychotic Use in Nursing Home Residents with Severe Dementia; Cluster Randomised Trial
BMJ 332:756-758,741, Fossey,J.,et al, 2006

Donepezil in Patients with Severe Alzheimers Disease: Double-Blind, Parallel-Group, Placebo-Controlled Study
Lancet 367:1057-1065,1031, Winblad,B.,et al, 2006

Mild Cognitive Impairment
Lancet 367:1262-1270, Gauthier,S.,et al, 2006

Neuropathologic Features of Amnestic Mild Cognitive Impairment
Arch Neurol 63:665-672,645, Petersen,R.C.,et al, 2006

Frontotemporal Dementia: Clinicopathological Correlations
Ann Neurol 59:952-962, Forman,M.S.,et al, 2006

Behavioral Effects of Memantine in Alzheimer Disease Patients Receiving Donepezil Treatment
Neurol 67:57-63, Cummings,J.L.,et al, 2006

Global Prevalence of Dementia: A Delphi Consensus Study
Lancet 366:2112-2117, Ferri,C.P.,et al, 2005

Diagnosis and Management of Dementia with Lewy Bodies
Neurol 65:1863-1872, McKeith,I.G.,et al, 2005

Bone Mineral Density and the Risk of Alzheimer Disease
Arch Neurol 62:107-111, Tan,Z.S.,et al, 2005

A 32-Year Prospective Study of Change in Body Weight and Incident Dementia
Arch Neurol 62:55-60,20, Stewart,R.,et al, 2005

Genetic Factors in Alzheimer's Disease
NEJM 352: 862-863, 884, Bird, T., 2005

Unawareness of Cognitive Deficit (Cognitive Anosognosia) in Probable AD and Control Subjects
Neurol 64:693-699, Barrett, A.M., et al, 2005

A-beta Vaccination Effects on Plaque Pathology in the Absence of Encephalitis in Alzheimer Disease
Neurol 64:129-131,10, Masliah,E.,et al, 2005

Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005

Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy
Arch Neurol 62:721-728, Mega,M.S.,et al, 2005

Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease
Arch Neurol 62:753-757, Sparks,D.L.,et al, 2005

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005

A 10-Item Smell Identification Scale Related to Risk for Alzheimers Disease
Ann Neurol 58:155-160, Taberr,M.H.,et al, 2005

Delusions and Hallucinations in Dementia with Lewy Bodies: Worsening with Memantine
Neurol 65:481-482, Ridha,B.H.,et al, 2005

The Role of Levodopa in the Management of Dementia With Lewy Bodies
JNNP 76:1200-1203, Moloy,S.,et al, 2005

Cholinesterase Inhibitors for Patients with Alzheimers Disease: Systematic Review of Randomised Clinical Trials
BMJ 331:321-323, Kaduszkiewicz,H.,et al, 2005

Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, Meta-analysis of Randomized Placebo-Controlled Trials
JAMA 294:1934-1943,1963, Schneider,L.S.,et al, 2005

Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005

Atypical Antipsychotic Drugs in the Treatment of Behavioural and Psychological Symptoms of Dementia: Systematic Review
BMJ 329:75-78, Lee,P.E.,et al, 2004

Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004

Alzheimer's Disease
NEJM 351:56-67, Cummings,J.L, 2004

The Efficacy of Donepezil in the Treatment of Neuropsychiatric Symptoms in Alzheimer Disease
Neurol 63:214-219,200, Holmes,C.,et al, 2004

Economic Evaluation of Donepezil in Moderate to Severe Alzheimer Disease
Neurol 63:644-650, Feldman,H.,et al, 2004

Driver Route-Following and Safety Errors in Early Alzheimer Disease
Neurol 63:832-837, Uc,E.Y.,et al, 2004

Progressive Posterior Cortical Dysfunction
Neurol 63:1175-1180, Renner,J.A.,et al, 2004

Clinical, Genetic, and Neuropathologic Characteristics of Posterior Cortical Atrophy
Neurol 63:1168-1174, Tang-Wai,D.F.,et al, 2004

Hyperinsulinemia and Risk of Alzheimer Disease
Neurol 63:1187-1192, Luchsinger,J.A.,et al, 2004

Autonomic Failure as the Initial Presentation of Parkinson Disease and Dementia with Lewy Bodies
Neurol 63:1093-1095, Kaufmann,H.,et al, 2004

Memory Complaints in Nondemented Men Predict Future Pathologic Diagnosis of Alzheimer Disease
Neurol 63:1960-1961, Jorm,A.F.,et al, 2004

Mixed Dementia, Emerging Concepts and Therapeutic Implications
JAMA 292:2901-2908, Langa,K.M.,et al, 2004

Preclinical Alzheimer Disease
Neurol 63:2341-2347, Saxton,J.,et al, 2004

Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements
Arch Neurol 61:82-88, Zandi,P.P.,et al, 2004

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004

Comparison of Different MRI Brain Atrophy Rate Measures with Clinical Disease Progression in AD
Neurol 62:591-600, Jack, Jr.,C.R.,et al, 2004

Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Arch Neurol 61:661-666, Arvanitakis,Z.,et al, 2004

Size of the Treatment Effect on Cognition of Cholinesterase Inhibition in Alzheimer's Disease
JNNP 75:677-685, Rockwood,K., 2004

Imaging Cerebral Atrophy:Normal Ageing to Alzheimer's Disease
Lancet 363:392-394, Fox,N.C.&Schott,J.M., 2004

Estimating Prognosis for Nursing Home Residents with Advanced Dementia
JAMA 291:2734-2740, Mitchell,S.L.,et al, 2004

Neuro-Ophthalmic Findings in the Visual Variant of Alzheimers Disease
Ophthalmology 111:376-381, Lee,A.G. &Martin,C.O., 2004

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003

Showing articles 150 to 200 of 2347 << Previous Next >>